Why Nano-X Imaging Stock Skyrocketed by 26% on Friday
The company could be in for a growth spurt in the near future.
Why AstraZeneca Stock Bumped Higher Today
The company is wasting little time figuring out the particulars of a sweeping capital investment program.
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years - IDEXX Laboratories ( NASDAQ:IDXX )
IDEXX Laboratories ( NASDAQ:IDXX ) has outperformed the market over the past 10 years by 14.09% on an annualized basis producing an average annual return of 26.23%. Currently, IDEXX Laboratories has a market capitalization of $58.83 billion.
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635 ( c ) ( 4 )
SAN CARLOS, Calif., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Iovance Biotherapeutics, Inc. ( NASDAQ: IOVA ) ( "Iovance" or the "Company" ) , a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte ( "TIL" ) therapies for patients with ...
Aging Americans Turn to Non-Invasive Knee Circulation Support: RejuvaCare RejuvaKnee Reports Growing Senior Demand for Triple Method Technology
Claymont, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice. The product discussed is a general wellness device, not a medical device. Consult a qualified healthcare professional before starting any new wellness ...
Here's How Much You Would Have Made Owning Alnylam Pharmaceuticals Stock In The Last 15 Years - Alnylam Pharmaceuticals ( NASDAQ:ALNY )
Alnylam Pharmaceuticals ( NASDAQ:ALNY ) has outperformed the market over the past 15 years by 17.12% on an annualized basis producing an average annual return of 29.2%. Currently, Alnylam Pharmaceuticals has a market capitalization of $57.65 billion.
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December
TEL AVIV, Israel, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) today announced that Richard Francis, Teva's President and CEO, and other members of executive management will present at three upcoming investor conferences in December as ...
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c ) ( 4 )
NOVATO, Calif., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Ultragenyx Pharmaceutical Inc. ( NASDAQ: RARE ) , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 18,180 restricted stock units of the ...
SNDL Announces Renewal of Share Repurchase Program
EDMONTON, Alberta, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- SNDL Inc. ( NASDAQ: SNDL, CSE: SNDL ) ( "SNDL" or the "Company" ) announced today that it has received approval from the Canadian Securities Exchange ( "CSE" ) for the renewal of its share repurchase program ( the "Share Repurchase Program" ...
Top Research Reports for JPMorgan Chase, Netflix & AbbVie
JPMorgan's year-to-date gains, NII growth outlook and investment banking pipeline headline today's standout Zacks research picks.
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
ROCKVILLE, Md., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Supernus Pharmaceuticals, Inc. ( Nasdaq: SUPN ) , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ( CNS ) diseases, announced today that Jack A.
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference - Supernus Pharmaceuticals ( NASDAQ:SUPN )
ROCKVILLE, Md., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Supernus Pharmaceuticals, Inc. ( NASDAQ:SUPN ) , a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system ( CNS ) diseases, announced today that Jack A.
P/E Ratio Insights for Agilent Technologies - Agilent Technologies ( NYSE:A )
In the current session, the stock is trading at $151.46, after a 4.41% increase. Over the past month, Agilent Technologies Inc. ( NYSE:A ) stock increased by 2.31%, and in the past year, by 12.61%.
Inventiva reports 2025 Third Quarter Financial Information¹
Daix ( France ) , New York City, ( New York, United States ) , November 21, 2025 - Inventiva ( Euronext Paris and Nasdaq: IVA ) ( "Inventiva" or the "Company" ) , a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic ...
Why Dyne Therapeutics Stock Was Crushing it This Week
The company has solid potential with its development of drugs targeting muscle disorders.
Why Are Shares of Pfizer Up Today? - Pfizer ( NYSE:PFE )
Shares of Pfizer, Inc. ( NASDAQ:PFE ) are trading higher after a study found that the company's new mRNA flu vaccine outperforms traditional shots against predominant strains. What To Know: A study published in the New England Journal of Medicine said that flu vaccine outperformed the ...
How Do Investors Really Feel About Tenet Healthcare Corp? - Tenet Healthcare ( NYSE:THC )
Tenet Healthcare Corp's ( NYSE:THC ) short interest as a percent of float has risen 3.62% since its last report. According to exchange reported data, there are now 2.62 million shares sold short, which is 4.01% of all regular shares that are available for trading.
Qatar's Emerging Appeal For MENA Investors: An ETF To Consider - iShares MSCI Qatar ETF ( NASDAQ:QAT )
Amid shifting global economic currents, one Gulf state is quietly reshaping its narrative. The State of Qatar, long known for its abundant natural gas reserves, is steadily repositioning itself as a dynamic investment destination.
FDA Flags Antibody Risk After Child's Death Linked To Takeda's Enzyme Replacement Therapy For Rare Blood Disorder - Takeda Pharmaceutical Co ( NYSE:TAK )
The U.S. Food and Drug Administration ( FDA ) on Friday said it has received postmarketing reports of neutralizing antibodies to ADAMTS13 in patients treated with Adzynma ( recombinant ADAMTS13 ) , including one pediatric death.
Where Will Crypto Be In 5 Years?
Is crypto's wild ride about to get even wilder? The old rules for predicting Bitcoin's price movements are broken. Here's why -- and what's replacing them.
Elanco Animal Health Stock Is Undervalued: Analyst - Elanco Animal Health ( NYSE:ELAN )
As the pet care industry experiences rapid growth, pharmaceutical companies are increasingly focusing on developing innovative treatments for companion animals. KeyBanc Capital Markets initiated coverage on Elanco Animal Health Incorporated ( NYSE:ELAN ) .
Behind the Scenes of Procter & Gamble's Latest Options Trends - Procter & Gamble ( NYSE:PG )
Whales with a lot of money to spend have taken a noticeably bullish stance on Procter & Gamble. Looking at options history for Procter & Gamble ( NYSE:PG ) we detected 10 trades. If we consider the specifics of each trade, it is accurate to state that 70% of the investors opened trades with ...
P/E Ratio Insights for Repligen - Repligen ( NASDAQ:RGEN )
In the current market session, Repligen Inc. ( NASDAQ:RGEN ) share price is at $155.36, after a 0.65% spike. Moreover, over the past month, the stock fell by 1.36%, but in the past year, spiked by 19.66%.
Looking for a Growth Stock? 3 Reasons Why Ensign Group ( ENSG ) is a Solid Choice
Ensign Group (ENSG) could produce exceptional returns because of its solid growth attributes.
3 Reasons Why Growth Investors Shouldn't Overlook Idexx ( IDXX )
Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
1 Reason Why Shares of Johnson & Johnson Are Surging This Month
A spate of promising news is helping to extend a post-earnings rally for the healthcare giant's shares.
Texas AG Sues Sanofi And Bristol-Myers Over Alleged Failures To Warn About Risks Associated With Blood Thinner Drug - Pfizer ( NYSE:PFE ) , Bristol-Myers Squibb ( NYSE:BMY ) , Sanofi ( NASDAQ:SNY )
Texas Attorney General Ken Paxton escalated his campaign against major drugmakers this week, filing a new lawsuit accusing Sanofi SA ( NASDAQ:SNY ) and Bristol-Myers Squibb Co ( NYSE:BMY ) of concealing critical information about the effectiveness of their blood-thinning medication Plavix.
Amneal EVP Sells $1.6 Million in Shares as Stock Trades Near Multi-Year Highs
One executive's option-linked sale may look large on paper, but the broader context tells a more nuanced story.
Zoetis Osteoarthritis Pain Franchise Needs A Reset: Analyst - Zoetis ( NYSE:ZTS )
As the animal health industry navigates a rapidly evolving landscape, companies are increasingly challenged to maintain their competitive edge through innovation and strategic adaptation.
DEADLINE ALERT for FUN, INSP, and TLX: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Inspire Medical Systems ( NYSE:INSP ) , Six Flags Entertainment ( NYSE:FUN )
LOS ANGELES, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Boston Scientific ( BSX ) Upgraded to Buy: Here's What You Should Know
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Viking Therapeutics ( VKTX ) Up 1% Since Last Earnings Report: Can It Continue?
Viking Therapeutics (VKTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
'Extremely lucky' solo Bitcoin miner beats massive odds to win $266K
A solo Bitcoin miner earned 3.146 BTC worth $266,000 with a computing power of only 1.2 TH/s, beating massive odds.
Halper Sadeh LLC Encourages FSUN, CADE, SNDA Shareholders to Contact the Firm to Discuss Their Rights - Cadence Bank ( NYSE:CADE ) , Firstsun Capital Bancorp ( NASDAQ:FSUN )
NEW YORK, Nov. 22, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Halper Sadeh LLC Encourages FRGE, BHF, HOLX Shareholders to Contact the Firm to Discuss Their Rights - Brighthouse Finl ( NASDAQ:BHF ) , Forge Global Holdings ( NYSE:FRGE )
NEW YORK, Nov. 22, 2025 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
3 Reasons to Buy Walmart Stock Like There's No Tomorrow
There's a new CEO coming in, but don't expect too many changes.
Is Avantor Stock a Buy After the CEO Scooped Up Nearly $1 Million in Shares?
The CEO's purchase demonstrates his confidence in Avantor stock's upside potential.
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX - Baxter Intl ( NYSE:BAX )
NEW YORK, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. ( NYSE:BAX ) between February 23, 2022 and July 30, 2025, both dates inclusive ( the "Class Period" ) , of the important ...
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global Healthcare Conference in December - Teva Pharmaceutical Indus ( NYSE:TEVA )
TEL AVIV, Israel, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Teva Pharmaceutical Industries Ltd. ( NYSE and TASE: TEVA ) today announced that Richard Francis, Teva's President and CEO, and other members of executive management will present at three upcoming investor conferences in December as follows:.
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference - Olema Pharmaceuticals ( NASDAQ:OLMA )
SAN FRANCISCO, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Olema Pharmaceuticals, Inc. ( ( "Olema", or "Olema Oncology", NASDAQ:OLMA ) , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today ... ET.
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
SAN FRANCISCO, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Olema Pharmaceuticals, Inc. ( "Olema", or "Olema Oncology", Nasdaq: OLMA ) , a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today ... ET.
Anchorage Digital adds HYPE staking support through Figment partnership
The integration gives institutions regulated access to HYPE staking on HyperCORE, extending Anchorage Digital's custody and DeFi capabilities across Hyperliquid.
Eli Lilly Stock Is Rising Today: Here's What You Need To Know - Eli Lilly ( NYSE:LLY )
Eli Lilly and Co ( NYSE:LLY ) shares are trading higher on Friday. The company plans to start selling its obesity drug through a new approach aimed at expanding access. What To Know: Eli Lilly is changing how it sells its well-liked obesity drugs.
Cramer On Housing Stock: 'No One's Buying Homes Here' - Netflix ( NASDAQ:NFLX ) , FuboTV ( NYSE:FUBO )
On CNBC's "Mad Money Lightning Round," on Thursday, Jim Cramer said he prefers Netflix, Inc. ( NASDAQ:NFLX ) over fuboTV Inc. ( NYSE:FUBO ) . FuboTV reported earnings for the third quarter of 2025 on Nov. 3.
Will Applied Digital's Second Campus Unlock the Next Leg of Growth?
APLD's new Polaris Forge 2 campus targets gigawatt-scale AI infrastructure as rising demand meets development constraints.
DEADLINE ALERT for LRN, PRMB, FCX, and PRGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders - Stride ( NYSE:LRN ) , Freeport-McMoRan ( NYSE:FCX )
LOS ANGELES, Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Deal Dispatch: Abbott, TPG, Lonza Make Major Moves; M&M Custard & New Fortress Energy Struggle - Abbott Laboratories ( NYSE:ABT ) , Comcast ( NASDAQ:CMCSA )
Swiss life sciences giant Lonza Group is shopping its capsules and health ingredients division, and the shortlist is full of private equity heavy-hitters. In the running: Altaris, Lone Star Funds, and One Rock Capital. Expected sale price: At least €2.5 billion ( US$2.8 billion ) .
Alation Named as a Leader 5x in the Gartner® Magic Quadrant™ for Metadata Management Solutions
REDWOOD CITY, Calif., Nov. 21, 2025 ( GLOBE NEWSWIRE ) -- Alation Inc., the data intelligence company, today announced it has been named a Leader in the Gartner® Magic Quadrant™ for Metadata Management Solutions for the fifth time.
Alation Named as a Leader 5x in the Gartner® Magic Quadrant™ for Metadata Management Solutions
Alation Named as a Leader 5x in the Gartner® Magic Quadrantâ„¢ for Metadata Management Solutions ...
3 Weight-Loss Drug Stocks To Consider For 2026 - Novo Nordisk ( NYSE:NVO ) , Eli Lilly ( NYSE:LLY )
The global weight loss drug market, perhaps ironically, is growing like gangbusters these days. Globally, it's set to expand from $15 billion in 2024 to $150 billion by 2035, according to Morgan Stanley.
